• Journal Article

Recurrence and survival predictive value of phenotypic expression of BCL2 varies with tumor stage of CRC adenocarcinomas

Citation

Chatla, C., Jhala, N., Katkoori, V., Alexander, D., Meleth, S., Grizzle, W., & Manne, U. (2005). Recurrence and survival predictive value of phenotypic expression of BCL2 varies with tumor stage of CRC adenocarcinomas. Cancer Biomarkers, 1(4-5), 241 - 250.

Abstract